Five common functional polymorphisms in microRNAs (rs2910164, rs2292832, rs11614913, rs3746444, rs895819) and the susceptibility to breast cancer: Evidence from 8361 cancer cases and 8504 controls

Current Pharmaceutical Design

Volumn 21, Issue 11, 2015, Pages 1455-1463

  Dai, Zhi Jun ^a,b   Shao, Yong Ping ^b   Wang, Xi Jing ^a   Xu, Dan ^b   Kang, Hua Feng ^a   Ren, Hong Tao ^a   Min, Wei Li ^a   Lin, Shuai ^a   Wang, Meng ^a   Song, Zhang Jun ^c  

^a THE SECOND AFFILIATED HOSPITAL OF XI AN JIAOTONG UNIVERSITY   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

^c Hospital of Shaanxi Province   (China)

Author keywords

Breast cancer; Cancer susceptibility; Meta analysis; MiRNAs; Single nucleotide polymorphism

Indexed keywords

MICRORNA; MICRORNA 146A; MICRORNA 149; MICRORNA 196A2; MICRORNA 27A; MICRORNA 499; UNCLASSIFIED DRUG; MIRN146 MICRORNA, HUMAN; MIRN196 MICRORNA, HUMAN; MIRN27 MICRORNA, HUMAN; MIRN499 MICRORNA, HUMAN;

ALLELE; ARTICLE; ASIAN; BREAST CANCER; CANCER RISK; CANCER SUSCEPTIBILITY; CAUCASIAN; DNA POLYMORPHISM; ETHNICITY; FEMALE; GENE FREQUENCY; GENETIC MODEL; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; PRIORITY JOURNAL; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST TUMOR; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; BREAST NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MICRORNAS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK;

EID: 84930973926     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612821666141208143533     Document Type: Article

References (43)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013; 63(1): 11-30.
2. McPherson K, Steel CM, Dixon JM. ABC of breast diseases. Breast cancer-epidemiology, risk factors, and genetics. BMJ 2000; 321: 624-8.
3. Hulka BS and Moorman PG. Breast cancer: hormones and other risk factors. Maturitas 2008; 61(1-2): 203-13.
4. Ruan K, Fang X, Ouyang G. MicroRNAs: novel regulators in the hallmarks of human cancer. Cancer Lett 2009; 285: 116-26.
5. Bentwich I, Avniel A, Karov Y, et al. Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet 2005; 37(7): 766-70.
6. Jovanovic M and Hengartner MO. miRNAs and apoptosis: RNAs to die for. Oncogene 2006; 25: 6176-87.
7. Iorio MV, Casalini P, Piovan C, Braccioli L, Tagliabue E. Breast cancer and microRNAs: Therapeutic impact. Breast 2011; 20: S63- 70.
8. Ryan BM, Robles AI, Harris CC. Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer 2010; 10: 389-402.
9. Christensen BC, Avissar-Whiting M, Ouellet LG, et al. Mature microRNA sequence polymorphism in MIR196A2 is associated with risk and prognosis of head and neck cancer. Clin Cancer Res 2010; 16(14): 3713-20.
10. Min KT, Kim JW, Jeon YJ, et al. Association of the miR- 146aC>G, 149C>T, 196a2C>T, and 499A>G polymorphisms with colorectal cancer in the Korean population. Mol Carcinog 2012; 51 Suppl 1: E65-73.
11. Ahn DH, Rah H, Choi YK, et al. Association of the miR-146aC>G, miR-149T>C, miR-196a2T>C, and miR-499A>G polymorphisms with gastric cancer risk and survival in the Korean population. Mol Carcinog 2013; 52 Suppl 1: E39-51.
12. Xu Y, Li L, Xiang X, et al. Three common functional polymorphisms in microRNA encoding genes in the susceptibility to hepatocellular carcinoma: a systematic review and meta-analysis. Gene 2013; 527(2): 584-93.
13. He B, Pan Y, Cho WC, et al. The association between four genetic variants in microRNAs (rs11614913, rs2910164, rs3746444, rs2292832) and cancer risk: evidence from published studies. PLoS One 2012; 7(11): e49032.
14. Zhong S, Chen Z, Xu J, Li W, Zhao J. Pre-mir-27a rs895819 polymorphism and cancer risk: a meta-analysis. Mol Biol Rep 2013; 40(4): 3181-6.
15. Omrani M, Hashemi M, Eskandari-Nasab E, et al. hsa-mir-499 rs3746444 gene polymorphism is associated with susceptibility to breast cancer in an Iranian population. Biomark Med 2014; 8(2): 259-67.
16. Zhang N, Huo Q, Wang X, et al. A genetic variant in pre-miR-27a is associated with a reduced breast cancer risk in younger Chinese population. Gene 2013; 529(1): 125-30.
17. Ma F, Zhang P, Lin D, et al. There is no association between microRNA gene polymorphisms and risk of triple negative breast cancer in a Chinese Han population. PLoS One 2013; 8(3): e60195.
18. Linhares JJ, Azevedo M Jr, Siufi AA, et al. Evaluation of single nucleotide polymorphisms in microRNAs (hsa-miR-196a2 rs11614913 C/T) from Brazilian women with breast cancer. BMC Med Genet 2012; 13: 119.
19. Zhang M, Jin M, Yu Y, et al. Associations of miRNA polymorphisms and female physiological characteristics with breast cancer risk in Chinese population. Eur J Cancer Care (Engl) 2012; 21(2): 274-80.
20. Catucci I, Verderio P, Pizzamiglio S, et al. The SNP rs895819 in miR-27a is not associated with familial breast cancer risk in Italians. Breast Cancer Res Treat 2012; 133(2): 805-7.
21. Alshatwi AA, Shafi G, Hasan TN, Syed NA, Al-Hazzani AA, et al. Differential expression profile and genetic variants of microRNAs sequences in breast cancer patients. PLoS One 2012; 7(2): e30049.
22. Jedlinski DJ, Gabrovska PN, Weinstein SR, Smith RA, Griffiths LR. Single nucleotide polymorphism in hsa-mir-196a-2 and breast cancer risk: a case control study. Twin Res Hum Genet 2011; 14(5): 417-21.
23. Garcia AI, Buisson M, Bertrand P, et al. Downregulation of BRCA1 expression by miR-146a and miR-146b-5p in triple negative sporadic breast cancers. EMBO Mol Med 2011; 3(5): 279-90.
24. Pastrello C, Polesel J, Della Puppa L, Viel A, Maestro R. Association between Hsa-miR-146a genotype and tumor age-of-onset in BRCA1/ BRCA2-negative familial breast and ovarian cancer patients. Carcinogenesis 2010; 31: 2124-6.
25. Catucci I, Yang R, Verderio P, et al. Evaluation of SNPs in miR- 146a, miR196a2 and miR-499 as low-penetrance alleles in German and Italian familial breast cancer cases. Hum Mutat 2010; 31(1): E1052-7.
26. Hoffman AE, Zheng T, Yi C, et al. microRNA miR-196a-2 and breast cancer: a genetic and epigenetic association study and functional analysis. Cancer Res 2009; 69(14): 5970-7.
27. Hu Z, Liang J, Wang Z, et al. Common genetic variants in premicroRNAs were associated with increased risk of breast cancer in Chinese women. Hum Mutat 2009; 30(1): 79-84.
28. Yang R, Schlehe B, Hemminki K, et al. A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk. Breast Cancer Res Treat 2010; 121: 693-702.
29. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 2009; 62: e1-e34.
30. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986; 7: 177-88.
31. Tang J, Ahmad A, Sarkar FH. The Role of MicroRNAs in Breast Cancer Migration, Invasion and Metastasis. Int J Mol Sci 2012; 13(10): 13414-37.
32. Xia L, Ren Y, Fang X, et al. Prognostic Role of Common MicroRNA Polymorphisms in Cancers: Evidence from a Meta- Analysis. PLoS One 2014; 9(10): e106799.
33. Zhang K, Zhang Y, Liu C, Xiong Y, Zhang J. MicroRNAs in the diagnosis and prognosis of breast cancer and their therapeutic potential (review). Int J Oncol 2014; 45(3): 950-8.
34. Peng S, Kuang Z, Sheng C, Zhang Y, Xu H, Cheng Q. Association of microRNA-196a-2 gene polymorphism with gastric cancer risk in a Chinese population. Dig Dis Sci 2010; 55(8): 2288-93.
35. Lv M, Dong W, Li L, et al. Association between genetic variants in pre-miRNA and colorectal cancer risk in a Chinese population. J Cancer Res Clin Oncol 2013; 139(8): 1405-10.
36. Akkız H, Bayram S, Bekar A, Akgöllü E, Ulger Y. A functional polymorphism in pre-microRNA-196a-2 contributes to the susceptibility of hepatocellular carcinoma in a Turkish population: a casecontrol study. J Viral Hepat 2011; 18(7): e399-407.
37. Yekta S, Shih IH, Bartel DP. MicroRNA-directed cleavage of HOXB8 mRNA. Science 2004; 304: 594-6.
38. Jazdzewski K, Murray EL, Franssila K, et al. (2008) Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci USA 2008; 105: 7269-74.
39. Chen QH, Wang QB, Zhang B. Ethnicity modifies the association between functional microRNA polymorphisms and breast cancer risk: a HuGE meta-analysis. Tumour Biol 2014; 35(1): 529-43.
40. Li X, Mertens-Talcott SU, Zhang S, Kim K, Ball J, Safe S. MicroRNA- 27a Indirectly Regulates Estrogen Receptor alpha Expression and Hormone Responsiveness in MCF-7 Breast Cancer Cells. Endocrinology 2010; 151(6): 2462-73.
41. Zhong S, Chen Z, Xu J, Li W, Zhao J. Pre-mir-27a rs895819 polymorphism and cancer risk: a meta-analysis. Mol Biol Rep 2013; 40(4): 3181-6.
42. Xiang Y, Fan S, Cao J, Huang S, Zhang LP. Association of the microRNA-499 variants with susceptibility to hepatocellular carcinoma in a Chinese population. Mol Biol Rep 2012; 39: 7019–23.
43. Li X, Wang J, Jia Z, et al. MiR-499 regulates cell proliferation and apoptosis during late-stage cardiac differentiation via Sox6 and cyclin D1. PLoS One 2013; 8(9): e74504.